{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:06:09Z","timestamp":1785819969381,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.acra.2022.12.027","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:55:44Z","timestamp":1672966544000},"page":"1805-1815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Accuracy of Preoperative Contrast-enhanced Cone Beam Breast CT in Assessment of Residual Tumor after Neoadjuvant Chemotherapy: A Comparative Study with Breast MRI"],"prefix":"10.1016","volume":"30","author":[{"given":"Yafei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiran","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiye","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.acra.2022.12.027_bib0001","doi-asserted-by":"crossref","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast cancer, version 3.2022, nccn clinical practice guidelines in oncology","volume":"20","author":"Gradishar","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"10.1016\/j.acra.2022.12.027_bib0002","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1016\/S1470-2045(19)30158-5","article-title":"Changing frameworks in treatment sequencing of triple-negative and HER2-positive, early-stage breast cancers","volume":"20","author":"Pusztai","year":"2019","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.acra.2022.12.027_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-017-4598-5","article-title":"Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes","volume":"168","author":"Volders","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.acra.2022.12.027_bib0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(17)30777-5","article-title":"Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials","volume":"19","year":"2018","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.acra.2022.12.027_bib0005","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/jmri.27145","article-title":"Role of MRI to assess response to neoadjuvant therapy for breast cancer","volume":"52","author":"Reig","year":"2020","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"10.1016\/j.acra.2022.12.027_bib0006","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.clbc.2016.12.010","article-title":"Role of magnetic resonance imaging in detection of pathologic complete remission in breast cancer patients treated with neoadjuvant chemotherapy: a meta-analysis","volume":"17","author":"Gu","year":"2017","journal-title":"Clin Breast Cancer"},{"issue":"2","key":"10.1016\/j.acra.2022.12.027_bib0007","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1245\/s10434-015-4876-6","article-title":"Microcalcifications in 1657 patients with pure ductal carcinoma in situ of the breast: correlation with clinical, histopathologic, biologic features, and local recurrence","volume":"23","author":"Rauch","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.acra.2022.12.027_bib0008","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/cancers12030609","article-title":"Ductal carcinoma in situ of the breast: an update with emphasis on radiological and morphological features as predictive prognostic factors","volume":"12","author":"Salvatorelli","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.acra.2022.12.027_bib0009","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejrad.2014.05.032","article-title":"Cone beam breast CT with multiplanar and three dimensional visualization in differentiating breast masses compared with mammography","volume":"84","author":"Zhao","year":"2015","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.acra.2022.12.027_bib0010","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1007\/s00330-021-08178-0","article-title":"Dedicated breast CT: state of the art-Part II. Clinical application and future outlook","volume":"32","author":"Zhu","year":"2022","journal-title":"Eur Radiol"},{"issue":"9","key":"10.1016\/j.acra.2022.12.027_bib0011","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1007\/s00330-018-5376-4","article-title":"Contrast-enhanced cone-beam breast-CT (CBBCT): clinical performance compared to mammography and MRI","volume":"28","author":"Wienbeck","year":"2018","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.acra.2022.12.027_bib0012","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s00330-018-5711-9","article-title":"Diagnostic accuracy of cone-beam breast computed tomography: a systematic review and diagnostic meta-analysis","volume":"29","author":"Uhlig","year":"2019","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.acra.2022.12.027_bib0013","first-page":"286","article-title":"The accuracy of tumor size evaluation on invasive breast cancer based on cone beam breast CT","volume":"53","author":"Ma","year":"2019","journal-title":"Chin J Radiol"},{"issue":"37","key":"10.1016\/j.acra.2022.12.027_bib0014","doi-asserted-by":"crossref","first-page":"e17082","DOI":"10.1097\/MD.0000000000017082","article-title":"Breast lesion size assessment in mastectomy specimens: Correlation of cone-beam breast-CT, digital breast tomosynthesis and full-field digital mammography with histopathology","volume":"98","author":"Wienbeck","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.acra.2022.12.027_bib0015","first-page":"2387","article-title":"Comparative analysis of contrast-enhanced cone beam breast CT, MRI and digital mammography measure size of breast non-mass lesions","volume":"10","author":"Zhong","year":"2020","journal-title":"Adv Clin Exp Med Clin (Barc)"},{"issue":"4","key":"10.1016\/j.acra.2022.12.027_bib0016","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1007\/s00330-020-07277-8","article-title":"Contrast-enhanced cone beam breast CT features of breast cancers: correlation with immunohistochemical receptors and molecular subtypes","volume":"31","author":"Ma","year":"2021","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.acra.2022.12.027_bib0017","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00330-019-06587-w","article-title":"Cone-beam breast CT features associated with HER2\/neu overexpression in patients with primary breast cancer","volume":"30","author":"Zhu","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2022.12.027_bib0018","article-title":"Assessment of cone-beam breast computed tomography for predicting pathologic response to neoadjuvant chemotherapy in breast cancer: a prospective study","volume":"2022","author":"Chen","year":"2022","journal-title":"J Oncol"},{"key":"10.1016\/j.acra.2022.12.027_bib0019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejrad.2017.12.003","article-title":"Contrast-enhanced cone-beam breast-CT: Analysis of optimal acquisition time for discrimination of breast lesion malignancy","volume":"99","author":"Uhlig","year":"2018","journal-title":"Eur J Radiol"},{"issue":"8","key":"10.1016\/j.acra.2022.12.027_bib0020","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1007\/s00330-022-08699-2","article-title":"Comparison of background parenchymal enhancement (BPE) on contrast-enhanced cone-beam breast CT (CE-CBBCT) and breast MRI","volume":"32","author":"Ma","year":"2022","journal-title":"Eur Radiol"},{"issue":"8","key":"10.1016\/j.acra.2022.12.027_bib0021","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","article-title":"Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015","volume":"26","author":"Coates","year":"2015","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.acra.2022.12.027_bib0022","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","article-title":"Intraclass correlations: uses in assessing rater reliability","volume":"86","author":"Shrout","year":"1979","journal-title":"Psychol Bull"},{"issue":"2","key":"10.1016\/j.acra.2022.12.027_bib0023","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1148\/radiol.2018172868","article-title":"Dynamic contrast-enhanced breast mri for evaluating residual tumor size after neoadjuvant chemotherapy","volume":"289","author":"Kim","year":"2018","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.acra.2022.12.027_bib0024","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/SLA.0b013e3182686bd9","article-title":"Breast cancer molecular phenotype and the use of her2-targeted agents influence the accuracy of breast mri after neoadjuvant chemotherapy","volume":"257","author":"Moon","year":"2013","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.acra.2022.12.027_bib0025","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1080\/02841860701373587","article-title":"Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI","volume":"46","author":"Kim","year":"2007","journal-title":"Acta Oncol"},{"key":"10.1016\/j.acra.2022.12.027_bib0026","first-page":"64","article-title":"Dedicated breast ct: feasibility for monitoring neoadjuvant chemotherapy treatment","volume":"4","author":"Vedantham","year":"2014","journal-title":"J Clin Imaging Sci"},{"issue":"6","key":"10.1016\/j.acra.2022.12.027_bib0027","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.diii.2020.01.001","article-title":"Optimal acquisition time to discriminate between breast cancer subtypes with contrast-enhanced cone-beam CT","volume":"101","author":"Chen","year":"2020","journal-title":"Diagn Interv Imaging"},{"issue":"3","key":"10.1016\/j.acra.2022.12.027_bib0028","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00330-021-08290-1","article-title":"Pre-treatment MRI tumor features and post-treatment mammographic findings: may they contribute to refining the prediction of pathologic complete response in post-neoadjuvant breast cancer patients with radiologic complete response on MRI?","volume":"32","author":"Thompson","year":"2022","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.acra.2022.12.027_bib0029","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1245\/s10434-016-5741-y","article-title":"Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised?","volume":"24","author":"Feliciano","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.acra.2022.12.027_bib0030","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1245\/s10434-015-4993-2","article-title":"Residual mammographic microcalcifications and enhancing lesions on mri after neoadjuvant systemic chemotherapy for locally advanced breast cancer: correlation with histopathologic residual tumor size","volume":"23","author":"Kim","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.acra.2022.12.027_bib0031","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12957-017-1263-8","article-title":"Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor","volume":"15","author":"An","year":"2017","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.acra.2022.12.027_bib0032","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1200\/JCO.2010.31.1258","article-title":"Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype","volume":"29","author":"Loo","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.acra.2022.12.027_bib0033","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10549-017-4254-0","article-title":"MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy","volume":"164","author":"van Ramshorst","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.acra.2022.12.027_bib0034","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1148\/radiol.2021203871","article-title":"Factors affecting pathologic complete response following neoadjuvant chemotherapy in breast cancer: development and validation of a predictive nomogram","volume":"299","author":"Kim","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2022.12.027_bib0035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40064-016-1800-x","article-title":"Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype","volume":"5","author":"Fukuda","year":"2016","journal-title":"Springerplus"},{"issue":"5","key":"10.1016\/j.acra.2022.12.027_bib0036","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/0284185115597263","article-title":"Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications","volume":"57","author":"Zhou","year":"2016","journal-title":"Acta Radiol"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633222006857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633222006857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:57:46Z","timestamp":1761037066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633222006857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1076633222006857"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2022.12.027","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accuracy of Preoperative Contrast-enhanced Cone Beam Breast CT in Assessment of Residual Tumor after Neoadjuvant Chemotherapy: A Comparative Study with Breast MRI","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2022.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}